Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Massimo Leoncini

MD - Head S.S.A. Cardiologia Interventistica

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy

About

Dr. Massimo Leoncini is an MD and the Head of the Interventional Cardiology Unit at Ospedale Civile di Sanremo, Italy. His research focuses on the management and outcomes of coronary artery disease, highlighted by recent publications on bioresorbable vascular scaffolds and the treatment of acute coronary syndromes. Dr. Leoncini's work emphasizes innovative techniques and regional disparities in myocardial infarction treatment.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Dario Calderone

IRCCS Istituto Auxologico Italiano

ITALY

View details

Enrico Romagnoli

Assistant Professor, fixed-term

Università Cattolica del Sacro Cuore

ITALY

View details

Giuseppe Massimo Sangiorgi

Ricercatore Confermato

Università degli Studi di Roma Tor Vergata Facoltà di Medicina e Chirurgia

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Massimo Leoncini

Research Interests

Make your next move.

Explore related searches

About

Articles (13)

One-Year Results of the Magmaris BRS in Coronary Artery Disease Patients: the IT-MASTERS Registry.

Percutaneous coronary interventions for aneurysmatic right coronary artery in acute coronary syndrome: RIGHTMARE registry outcomes

Regional disparities in the management and outcomes of ST-elevation myocardial infarction: an Italian analysis focusing on time-dependent reperfusion networks and in-hospital logistics.

Five-year clinical outcomes of STEMI patients treated with a pre-specified bioresorbable vascular scaffold implantation technique: Final results of the BVS STEMI STRATEGY-IT.

Effectiveness of the DyeVert Power XT system during percutaneous coronary interventions

Comparison of acute versus stable coronary syndrome in patients treated with the Magmaris scaffold: Two-year results from the Magmaris Multicenter Italian Registry

[Effectiveness of the DyeVert Power XT system during percutaneous coronary interventions].

Power Flush, a novel bail-out technique for stumpless aorto-ostial CTOs. A case-based approach

Sustained safety and efficacy of magnesium reabsorbable scaffold. 2-year follow-up analysis from first Magmaris multicenter Italian registry

Three-year results of ST-segment elevation myocardial infarction patients treated with a prespecified bioresorbable vascular scaffold implantation strategy: bVS STEMI STRATEGY-IT long-term.

Unplanned Percutaneous Coronary Revascularization After TAVR

ImpaCt of an optimal Implantation strategy on Absorb long-term Outcomes: the CIAO Registry

IntravaScular lithotripsy for the Management of undILatable coronary stEnt: The SMILE Registry

Collaborators (3)

Dario Calderone

Enrico Romagnoli

Giuseppe Massimo Sangiorgi

Make your next move.